| DODGX | MABAX | DODGX / MABAX | |
| Total Expense Ratio | 0.51 | 0.54 | 94% |
| Annual Report Gross Expense Ratio | 0.51 | 0.54 | 94% |
| Fund Existence | 61 years | 48 years | - |
| Gain YTD | 12.037 | 9.905 | 122% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 2000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 119B | 1.94B | 6,128% |
| Annual Yield % from dividends | 1.32 | 2.97 | 45% |
| Returns for 1 year | 3.03 | 6.17 | 49% |
| Returns for 3 years | 29.74 | 26.16 | 114% |
| Returns for 5 years | 50.51 | 18.82 | 268% |
| Returns for 10 years | 83.18 | 12.13 | 686% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VBK | 312.79 | 3.75 | +1.21% |
| Vanguard Small-Cap Growth ETF | |||
| DEUS | 59.15 | 0.62 | +1.06% |
| Xtrackers Russell US Multifactor ETF | |||
| IHE | 84.11 | 0.71 | +0.85% |
| iShares US Pharmaceuticals ETF | |||
| OCTM | 32.58 | 0.02 | +0.05% |
| FT Vest U.S. Equity Max Buffer ETF – Oct | |||
| SCDL | 37.75 | N/A | N/A |
| ETRACS 2x Leveraged US Div Fctr TR ETN | |||